Learn More
Medchemexpress LLC 4-(Diphenylmethoxy)-1-[3-(1H-tetrazol-5-yl)propyl]piperidine | 162641-16-9 | MFCD00936179 | >98.0% | 377.5 g/mol | C22H27N5O | 50 MG

Supplier: Medchemexpress LLC HY10825950MG
HQL-79 (CAS 162641-16-9) is a selective hematopoietic prostaglandin D synthase (H-PGDS) inhibitor supplied for research use. It is orally active in biological assays and inhibits PGD2 synthesis, with reported biochemical potency (IC50 ≈ 6 μM; Kd ≈ 0.8 μM). The compound is supplied as a crystalline solid (C22H27N5O; MW 377.5 g/mol) and is typically stored frozen to preserve integrity.
- Selective H-PGDS inhibitor for mechanistic studies.
- Reported IC50 ≈ 6 μM and Kd ≈ 0.8 μM.
- Orally active in biological assays.
- High purity (reported >98%).
- Crystalline solid with formula C22H27N5O and MW 377.5 g/mol.
- Recommended storage at -20°C to maintain stability.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.